Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
S&P Global
SPGI
|
+$1B |
| 3 |
GE Aerospace
GE
|
+$681M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$402M |
| 5 |
Enterprise Products Partners
EPD
|
+$374M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$807M |
| 2 |
SNDK
SANDISK CORP
SNDK
|
+$617M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$544M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$542M |
| 5 |
Monster Beverage
MNST
|
+$521M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 8.93% |
| 2 | Technology | 8.69% |
| 3 | Financials | 8.37% |
| 4 | Communication Services | 6.94% |
| 5 | Consumer Staples | 6.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Pfizer
PFE
$143B
| $1.29B | 0.46% |
38,473,415
+832,620
| +2% | +$26.6M |
|
27
Amgen
AMGN
$209B
| $1.22B | 0.44% |
8,039,376
+148,772
| +2% | +$23.1M |
|
28
Berkshire Hathaway Class B
BRK.B
$1.1T
| $1.16B | 0.42% |
8,015,059
+582,460
| +8% | +$83.3M |
|
29
Procter & Gamble
PG
$340B
| $1.16B | 0.42% |
13,644,497
+31,023
| +0.2% | +$2.55M |
|
30
SLB Ltd
SLB
$72.7B
| $1.15B | 0.42% |
14,529,860
+690,069
| +5% | +$52.9M |
|
31
Nike
NKE
$64.1B
| $1.14B | 0.41% |
20,674,106
+3,571,669
| +21% | +$203M |
|
32
RTX Corp
RTX
$290B
| $1.14B | 0.41% |
17,620,542
+3,241,212
| +23% | +$207M |
|
33
Salesforce
CRM
$154B
| $1.14B | 0.41% |
14,307,446
+3,761,675
| +36% | +$295M |
|
34
IBM
IBM
$213B
| $1.13B | 0.41% |
7,773,026
+1,462,522
| +23% | +$209M |
|
|
35
Enterprise Products Partners
EPD
$83.7B
| $1.12B | 0.41% |
38,379,290
+13,945,721
| +57% | +$374M |
|
36
Home Depot
HD
$337B
| $1.12B | 0.41% |
8,788,596
+350,183
| +4% | +$46.3M |
|
|
RAI
37
DELISTED
Reynolds American Inc
RAI
| $1.12B | 0.4% |
20,716,625
+1,703,653
| +9% | +$85.6M |
|
38
Wells Fargo
WFC
$254B
| $1.1B | 0.4% |
23,341,800
-412,164
| -2% | -$20.1M |
|
39
Bristol-Myers Squibb
BMY
$129B
| $1.09B | 0.39% |
14,844,777
+708,652
| +5% | +$50.1M |
|
40
iShares S&P 500 Growth ETF
IVW
$70.5B
| $1.06B | 0.38% |
36,520,712
-699,884
| -2% | -$20.3M |
|
41
Accenture
ACN
$106B
| $1.01B | 0.37% |
8,951,618
+302,675
| +3% | +$35.1M |
|
|
42
S&P Global
SPGI
$124B
| $1B | 0.36% |
+9,342,671
| New | +$1B |
|
43
Coca-Cola
KO
$383B
| $995M | 0.36% |
21,956,014
+5,949,723
| +37% | +$269M |
|
44
Blackstone
BX
$104B
| $991M | 0.36% |
40,366,822
-8,092,760
| -17% | -$215M |
|
45
iShares MSCI EAFE ETF
EFA
$76.4B
| $951M | 0.34% |
17,032,488
+4,768,872
| +39% | +$274M |
|
46
Comcast
CMCSA
$87.3B
| $947M | 0.34% |
29,043,930
+696,604
| +2% | +$21.6M |
|
47
Mondelez International
MDLZ
$82.9B
| $943M | 0.34% |
20,716,575
-6,415,504
| -24% | -$280M |
|
48
Equity Residential
EQR
$25.8B
| $920M | 0.33% |
13,356,101
-242,249
| -2% | -$16.7M |
|
49
Medtronic
MDT
$112B
| $900M | 0.33% |
10,373,527
-913,882
| -8% | -$73.9M |
|
50
Vornado Realty Trust
VNO
$7.65B
| $887M | 0.32% |
10,959,257
+347,408
| +3% | +$26.9M |
|
Similar funds
Morgan Stanley's Q2 2016 Portfolio in Review
As of Q2 2016, Morgan Stanley held 7,048 positions worth $277B, up 6.5% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Morgan Stanley deployed $10.3B of net new capital in Q2 2016, opening 169 new positions and adding to 3,077 existing holdings. Its largest new stake was S&P Global: 9,342,671 shares worth $1B.
By sector, the portfolio is most concentrated in Healthcare at 8.9% of assets, down from 9.1% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $542M trimmed.
- Morgan Stanley's largest Q2 2016 buy was S&P Global: 9,342,671 shares worth $1B.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $1.11B increase.
- Morgan Stanley's biggest Q2 2016 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $542M.
- Morgan Stanley fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $807M.
- Morgan Stanley's ten largest holdings make up 13% of its $277B portfolio in Q2 2016.
- Morgan Stanley opened 169 new positions and closed 401 in Q2 2016.
- Morgan Stanley's portfolio value rose 6.5% quarter-over-quarter to $277B.
Based on Morgan Stanley's 13F filing for Q2 2016, filed 12 Aug 2016.